Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Syndicated Credit Facility

1 Oct 2008 07:00

RNS Number : 7747E
Kingspan Group PLC
01 October 2008
 



October 2008

Kingspan Group Plc

Kingspan agrees new €330 million syndicated credit facility

Kingspan Group plc, the leading international manufacturer of a range of sustainable products for the construction industry, announces the successful placement yesterday of a syndicated credit facility of €330 million.

The funding, which was oversubscribed, has been put in place to facilitate Kingspan's organic and acquisition growth plans over the next 5 years, and replaces the previous syndicated facility which was due to run until December 2009

 

Dermot Mulvihill, Group Finance Director commented: "The syndicated credit facility provides a platform to continue our stated strategy of expansion by organic growth, strategic investment and acquisitions. Kingspan is pleased that in the current banking environment its banks, including a number of new lenders, have expressed confidence in Kingspan's business model."

 

IIB Bank plc/KBC Bank NV were the sole Bookrunner. Mandated Lead Arrangers are IIB Bank plc / KBC Bank NV, Ulster Bank Ireland Limited and Bank of Ireland. Other Arrangers are Allied Irish Banks plc., HSBC Bank plc. and BNP Paribas. 

For further information please contact: 

Murray Consultants Ed Micheau

+353 (0)1 4980300

Buchanan Communications Tim Thompson/Jeremy Garcia

+44 (0)20 7466 5000

Kingspan Group Plc.

Lorcan Dowd, Company Secretary 

+ 353 (0)42 9698000 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFFFIARIIVIT
Date   Source Headline
18th Aug 20237:05 amRNSDelisting from the London Stock Exchange
18th Aug 20237:00 amRNSHalf-year Report
20th Jul 202311:37 amRNSResult of EGM
20th Jul 20239:56 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSAcquisition
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20232:40 pmRNSBlock listing Interim Review
3rd Jul 20232:34 pmRNSTotal Voting Rights
30th Jun 20234:54 pmRNSHolding(s) in Company
26th Jun 20232:00 pmRNSCircular and Notice of EGM
23rd Jun 20234:08 pmRNSHolding(s) in Company
14th Jun 20234:56 pmRNSHolding(s) in Company
14th Jun 20234:54 pmRNSHolding(s) in Company
1st Jun 20235:25 pmRNSTotal Voting Rights
2nd May 20235:09 pmRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirectorate Change
28th Apr 20234:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
3rd Apr 20234:40 pmRNSTotal Voting Rights
30th Mar 20239:00 amRNSDirector/PDMR Shareholding
21st Mar 20235:24 pmRNSDirector/PDMR Shareholding
20th Mar 20235:29 pmRNSHolding(s) in Company
20th Mar 20235:28 pmRNSHolding(s) in Company
16th Mar 20234:29 pmRNSHolding(s) in Company
16th Mar 20232:05 pmRNSNotice of AGM
1st Mar 20234:28 pmRNSTotal Voting Rights
1st Mar 20233:33 pmRNSHolding(s) in Company
1st Mar 202312:39 pmRNSDirector/PDMR Shareholding
28th Feb 20231:11 pmRNSDirector/PDMR Shareholding
24th Feb 20231:09 pmRNSHolding(s) in Company
23rd Feb 20234:57 pmRNSAnnual Financial Report
23rd Feb 20239:00 amRNSDirector/PDMR Shareholding
21st Feb 20235:34 pmRNSDirector/PDMR Shareholding
21st Feb 20235:28 pmRNSDirector/PDMR Shareholding
17th Feb 20237:30 amRNSDirectorate Change
17th Feb 20237:00 amRNSFinal Results
13th Feb 20236:02 pmRNSHolding(s) in Company
10th Feb 20233:00 pmRNSHolding(s) in Company
8th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20232:12 pmRNSHolding(s) in Company
2nd Feb 20234:27 pmRNSHolding(s) in Company
30th Jan 20232:48 pmRNSHolding(s) in Company
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20234:05 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20234:40 pmRNSHolding(s) in Company
3rd Jan 20239:05 amRNSBlock listing Interim Review
3rd Jan 20239:00 amRNSTotal Voting Rights
21st Dec 20224:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.